Thermobalancing therapy, is an advanced medical technology known for its effective and safe approach to treating men with chronic prostatitis and benign prostatic hyperplasia (BPH). And now it has been announced that this therapy is effective in the treatment of chronic prostatitis in men with an enlarged prostate or BPH.
Medications and surgical treatments for chronic prostatitis and BPH carry high risks, so men are looking for safer alternatives. Thermobalancing therapy with Dr Allen’s Device has been granted a U.S. patent for “Therapeutic Device and Method” and has been shown to be effective in treating chronic prostatitis, BPH, and even reversing prostate enlargement.
Fine Treatment Offers Dr Allen’s Device for Prostate Treatment
Fine Treatment, an Oxford-based company in the UK, manufactures and ships Dr Allen’s Device to men around the world by a Royal mail tracked service. Dr Allen’s Device is classified as a Class I medical device, non-invasive, and does not require notified body certification, so any man can use it at home without any concerns.
Clinical studies in men with BPH and chronic prostatitis have demonstrated the high efficacy of Dr Allen’s device in removing pain and urinary dysfunction symptoms by treating the diseased prostate gland naturally.
Symptoms of Chronic Prostatitis and BPH
Overall, 2 to 10% of men suffer from chronic prostatitis, and around 14 million men in the USA have urination symptoms related to BPH, which can affect 50% of men aged between 51 and 60 years, and this percentage increases with age.
Lower urinary tract symptoms caused by prostate enlargement or BPH include frequent urination during the day and at night, a weak urine flow, etc. Men with chronic prostatitis may also experience lower urinary tract symptoms, but the main symptom is pain, which is often localized in the perineum or lower back.
Drugs and Surgeries for Chronic Prostatitis and BPH
Several recent scientific studies have shown that drugs for chronic prostatitis and BPH alpha-blockers and 5-alpha-reductase inhibitors have serious side effects. Chronic prostatitis drugs also include NSAIDs (non-steroidal anti-inflammatory drugs) or paracetamol for pain management.
The article “Comparative efficacy of tamsulosin and finasteride in the management of BPH”, states that alpha blockers, such as tamsulosin (Flomax) and others, may be associated with a higher incidence of dizziness, whereas finasteride has been shown to significantly increase sexual dysfunction.
The article “Beyond the Prostate: A visionary study on ocular impacts of BPH drugs” showed that BPH drugs, alpha-1 antagonists and 5-ARIs, cause ocular adverse effects such as retinal symptoms, dacryocystitis, xerophthalmia, and other inflammatory processes in the eye.
The use of nonsteroidal anti-inflammatory drugs (NSAIDs) to treat chronic prostatitis, such as ibuprofen, naproxen, and aspirin, often causes gastrointestinal problems, including stomach pain, indigestion, nausea, and ulcers.
However, it should be noted that BPH is non-malignant enlargement. Therefore, treatment of this chronic disease should be safe in the first place. Therefore, men should carefully choose a treatment method for chronic prostatitis and BPH – an inflamed or enlarged prostate gland.
Forecast of Chronic Prostatitis and BPH Drugs Market
An increase in the male geriatric population leads to an increase rate of BPH and to a consequent increased demand for BPH drugs.
The global BPH drugs market was valued at $10,688.72 million in 2017 and is projected to reach $20,096.68 million by 2025 at a CAGR of 8.1% from 2018 to 2027.
In the article “Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia” combination prescription drug therapy (“ComboRx”), an inhibitor of 5α-reductase (e.g., dutasteride or finasteride), and an α-selective adrenergic receptor blocker (e.g., tamsulosin or doxazosin) were examined.
The article concluded that the medication option is the least expensive but not cost-effective, as this modality requires extended use to barely achieve half the urinary symptom. According to this article, complications and side effects after these standard treatments of BPH include acute urinary retention, erectile dysfunction, incontinence, stricture, contracture or stenosis, urinary tract infection.
That is why men before the use of BPH drugs or surgeries must be aware about of health problems they can face in the future. Sexual dysfunction and depression are the most common annoying adverse events after standard treatment options of BPH.
Dr Allen’s Device Should Be the First Choice for Chronic Prostatitis and BPH
Dr Allen’s Device for Prostate Treatment consists of a thermoelement, which is made from the special mixture of waxes, and the belt that applies this thermoelement tightly to the skin. Thermoelement accumulates the body heat and becomes the source of energy itself.
There are some important features that make Thermobalancing therapy unique:
- The temperature of the therapy must not exceed the body temperature.
- The device must apply the thermoelement tightly to the skin in the projection of the affected prostate gland.
- Therapy must be used for the continuous period of time.
Thus, Thermobalancing therapy improves men’s health and well-being without any side effects or complications.